AF
AERI

Amalgamated Financial’s Aerie Pharmaceuticals AERI Stock Holding History

Amalgamated Financial’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$63K Buy
+6,914
New +$53.3K ﹤0.01% 2316

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Amalgamated Financial's AERI Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Aerie Pharmaceuticals (AERI) in Q1 2022: 6,914 shares worth $63K. The stake represents ﹤0.01% of the portfolio and ranks #2316 among its holdings.

136 funds tracked by Wall St. Rank hold AERI as of Q1 2022.

  • Amalgamated Financial held 6,914 shares of Aerie Pharmaceuticals worth $63K as of Q1 2022.
  • Aerie Pharmaceuticals was a new Amalgamated Financial position in Q1 2022.
  • Aerie Pharmaceuticals made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2316 holding.
  • 136 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.